Craig-Hallum Maintains Buy on CareDx, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Connor Chamberlain maintains a Buy rating on CareDx (NASDAQ:CDNA) and raises the price target from $15 to $22.
May 17, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum analyst Connor Chamberlain maintains a Buy rating on CareDx and raises the price target from $15 to $22.
The raised price target from $15 to $22 by a reputable analyst suggests increased confidence in CareDx's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100